Online citations, reference lists, and bibliographies.
← Back to Search

Nanopharmaceuticals: A New Perspective Of Drug Delivery System

Md. Zubayer Hossain Saad, R. Jahan, Uddhav Bagul
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Nano-sized objects can be transformed in numerous ways to alter their characteristics. Drug molecules sized in nanometre range provide some unique features which can lead to prolonged circulation, improved drug localization, enhanced drug efficacy etc.; and these increased performance come through a variety of dosage forms. In fact, wide spectrum application of nanotechnology in pharmaceutical formulations is changing the scientific landscape of prevention, diagnosis and treatment of diseases. Various pharmaceutical nanotechnology based systems which can be termed as Nanopharmaceuticals like liposomes, carbon nanotubes, quantum dots, dendrimaers, polymeric nanoparticles, metallic nanoparticles etc. have brought about revolutionary changes in drug delivery as well as the total medical service system. The present review summarizes the most important applications of nanotechnology in drug delivery systems.
This paper references
10.1039/b923560d
Enhanced anticancer activity of multi-walled carbon nanotube-methotrexate conjugates using cleavable linkers.
Cristian Samorí (2010)
10.1021/nn900201e
Functional Delivery of siRNA in Mice Using Dendriworms
A. Agrawal (2009)
10.1016/j.addr.2009.11.022
Nano-microbicides: challenges in drug delivery, patient ethics and intellectual property in the war against HIV/AIDS.
L. D. du Toit (2010)
10.1016/j.nano.2009.12.006
Doxorubicin-loaded solid lipid nanoparticles to overcome multidrug resistance in cancer therapy.
K. W. Kang (2010)
Formulation and evaluation of ethosomes for transdermal delivery of lamivudine. AAPS PharmSciTech
S Jain (2007)
10.1039/B204287H
Phosphorus-containing dendrimers bearing galactosylceramide analogs: self-assembly properties.
M. Blanzat (2002)
10.1016/S0169-409X(97)00136-1
Controlling liposome blood clearance by surface-grafted polymers.
Woodle (1998)
10.1002/CHEM.200700987
New carbon materials: biological applications of functionalized nanodiamond materials.
A. Krueger (2008)
10.1039/c1cc00075f
Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water-soluble anticancer drug: a comparative study.
N. G. Sahoo (2011)
10.1016/j.biomaterials.2009.08.049
Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
Weilun Ke (2009)
10.1021/AR700089B
Functionalized carbon nanotubes in drug design and discovery.
M. Prato (2008)
10.1016/j.jconrel.2010.05.027
Relevance of folic acid/polymer ratio in targeted PEG-epirubicin conjugates.
F. Canal (2010)
10.1089/HUM.1998.9.4-553
Efficient transfer of genes into murine cardiac grafts by Starburst polyamidoamine dendrimers.
L. Qin (1998)
10.1016/j.jconrel.2010.11.022
G3.5 PAMAM dendrimers enhance transepithelial transport of SN38 while minimizing gastrointestinal toxicity.
Deborah S. Goldberg (2011)
10.1021/JA050062V
Carbon nanotubes as intracellular protein transporters: generality and biological functionality.
N. W. Kam (2005)
10.1016/J.YMTHE.2003.07.007
Transfection of airway epithelium by stable PEGylated poly-L-lysine DNA nanoparticles in vivo.
A. Ziady (2003)
10.1023/A:1011050209986
Targeting of 3′-Azido 3′-Deoxythymidine (AZT)-Loaded Poly(Isohexylcyanoacrylate) Nanospheres to the Gastrointestinal Mucosa and Associated Lymphoid Tissues
Assia Dembri (2004)
10.3109/10611869808995872
Improved body distribution of 14C-labelled AZT bound to nanoparticles in rats determined by radioluminography.
R. Löbenberg (1998)
10.1208/s12249-009-9373-4
Ciprofloxacin as Ocular Liposomal Hydrogel
K. Hosny (2009)
10.22377/AJP.V2I1.157
Polymers used in ocular dosage form and drug delivery systems
V. Wagh (2008)
10.1016/j.jconrel.2010.02.006
Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.
R. Patlolla (2010)
10.1016/j.jconrel.2008.11.027
One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Katsuya Ohashi (2009)
10.1016/j.biomaterials.2011.07.004
Aptamer-functionalized PEG-PLGA nanoparticles for enhanced anti-glioma drug delivery.
Jianwei Guo (2011)
10.1515/9783111576855-012
G
G.V.T.V. Weerasooriya (1824)
10.1006/PHRS.1999.0509
Pharmacokinetics of doxorubicin incorporated in solid lipid nanospheres (SLN).
G. Zara (1999)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1081/CUS-200059582
Preparation and Characterization of Demeclocycline Liposomal Formulations and Assessment of their Intraocular Pressure-Lowering Effects
M. Afouna (2005)
10.1023/A:1018888927852
Body Distribution of Camptothecin Solid Lipid Nanoparticles After Oral Administration
Shicheng Yang (2004)
10.3109/09687688.2010.507788
Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications
Amichai Yavlovich (2010)
10.1016/S0142-9612(99)00125-8
Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.
C. E. Soma (2000)
10.1016/J.IJPHARM.2006.03.052
Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.
S. Azarmi (2006)
10.1007/978-0-387-76713-0_4
Multi-functional gold nanoparticles for drug delivery.
G. Han (2007)
10.1080/02772240903503955
Quantum dots enhance Cu2+-induced hepatic l02 cells toxicity: involvement of Nrf2
Y. Zhao (2010)
10.1017/CBO9781139207249.009
I and J
William M. Marsden (2012)
10.1016/J.BIOMATERIALS.2007.11.014
Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.
L. Liu (2008)
10.1093/JAC/DKG477
Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.
R. Pandey (2003)
10.2217/17435889.3.2.175
Carbon nanotubes filled with a chemotherapeutic agent: a nanocarrier mediates inhibition of tumor cell growth.
S. Hampel (2008)
10.1007/s11060-009-9917-1
Non-PEGylated liposomes for convection-enhanced delivery of topotecan and gadodiamide in malignant glioma: initial experience
A. Grahn (2009)
10.1038/SJ.JID.5700733
Penetration of metallic nanoparticles in human full-thickness skin.
B. Baroli (2007)
10.1016/j.biomaterials.2009.11.077
Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers.
Caihong Zhu (2010)
10.1002/anie.200902612
Supramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapy.
Zhuang Liu (2009)
10.1158/1078-0432.CCR-08-0515
Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors
G. Batist (2009)
10.1358/MF.2001.23.10.677118
Pulmonary disposition of budesonide from liposomal dry powder inhaler.
M. Joshi (2001)
10.1073/pnas.0607705103
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas
C. Lee (2006)
10.1021/bc700477u
Bioconjugated quantum rods as targeted probes for efficient transmigration across an in vitro blood-brain barrier.
G. Xu (2008)
10.1038/nrd2153
Inhaling medicines: delivering drugs to the body through the lungs
John S. Patton (2007)
10.1046/j.1440-1681.2003.03813.x
Disposition kinetics of ketotifen from liposomal dry powder for inhalation in rat lung
M. Joshi (2003)
10.1007/s11060-009-9945-x
Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors
Weilian Yang (2009)
10.3109/10611869909085490
Aerosolization of low phase transition temperature liposomal tobramycin as a dry powder in an animal model of chronic pulmonary infection caused by Pseudomonas aeruginosa.
C. Beaulac (1999)
10.1080/10611860600635608
Delivery of hydrophobised 5-fluorouracil derivative to brain tissue through intravenous route using surface modified nanogels
Sheetal Soni (2006)
10.1016/S0140-6736(05)61503-6
T
D. Davies (1998)
10.1016/J.IJPHARM.2006.07.044
Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier.
Y. Kuo (2006)
10.1021/NL052405T
Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects.
W. Cai (2006)
10.1016/j.ejps.2008.04.002
Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.
T. Dutta (2008)
10.1016/j.brainres.2009.05.047
MMP-9 gene silencing by a quantum dot–siRNA nanoplex delivery to maintain the integrity of the blood brain barrier
Adela C. Bonoiu (2009)
10.1016/j.biomaterials.2008.12.010
Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His.
B. Feng (2009)
10.1088/0957-4484/21/8/085103
Platinum nanoparticles: a promising material for future cancer therapy?
E. Porcel (2010)
10.2174/157016210791330356
Enhancing the delivery of anti retroviral drug "Saquinavir" across the blood brain barrier using nanoparticles.
S. Mahajan (2010)
10.4161/cbt.7.6.5912
Paclitaxel-loaded poly(D,L-lactide-co-glycolide) nanoparticles for radiotherapy in hypoxic human tumor cells in vitro
C. Jin (2008)
10.1093/jac/dkr002
Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
V. Prajapati (2011)
10.1128/JVI.01137-06
Removal of Divalent Cations Induces Structural Transitions in Red Clover Necrotic Mosaic Virus, Revealing a Potential Mechanism for RNA Release
M. Sherman (2006)
10.1039/b712350g
Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics.
Hanene Ali-Boucetta (2008)
10.1074/jbc.M110.125906
Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer*
Yunching Chen (2010)
10.1016/j.ijpharm.2009.06.020
Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery.
N. Li (2009)
10.1016/S0378-5173(98)00236-1
Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice
H. Heiati (1998)
10.1002/mabi.200800085
Interactions between an anticancer drug and polymeric micelles based on biodegradable polyesters.
Xiaoqiang Yang (2008)
10.1073/PNAS.92.12.5592
Vector-mediated delivery of a polyamide ("peptide") nucleic acid analogue through the blood-brain barrier in vivo.
W. Pardridge (1995)
10.1016/j.addr.2007.11.006
Targeted delivery of nanoparticles for the treatment of lung diseases.
S. Azarmi (2008)
10.1093/TOXSCI/KFJ122
Penetration of intact skin by quantum dots with diverse physicochemical properties.
Jessica P. Ryman-Rasmussen (2006)
10.1007/s11095-006-9122-2
Transport of Poly(Amidoamine) Dendrimers across Caco-2 Cell Monolayers: Influence of Size, Charge and Fluorescent Labeling
Kelly M. Kitchens (2006)
10.1016/J.JCONREL.2006.03.014
Pulmonary delivery of insulin by liposomal carriers.
Y. Huang (2006)
Nanoparticle-mediated delivery of nuclear factor {kappa}B decoy into lungs ameliorates monocrotaline-induced pulmonary arterial hypertension. Hypertension
S Kimura (1930)
MMP9 gene silencing by a quantum dot-siRNA nanoplex delivery to maintain the integrity of the blood brain barrier
A Bonoiu (2009)
10.1016/J.BBAGEN.2006.12.007
Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
T. Dutta (2007)
10.1067/MAI.2003.104
Efficacy of liposomal budesonide in experimental asthma.
K. Konduri (2003)
10.1016/J.BMCL.2006.06.069
In vitro study of drug accumulation in cancer cells via specific association with CdS nanoparticles.
J. Li (2006)
10.1016/S0169-409X(02)00044-3
Nanoparticles in cancer therapy and diagnosis.
I. Brigger (2002)
10.1002/JPS.20849
Dendrimers as a carrier for pulmonary delivery of enoxaparin, a low-molecular weight heparin.
Shuhua Bai (2007)
10.1155/2011/408675
Emerging technologies of polymeric nanoparticles in cancer drug delivery
E. Brewer (2011)
10.1038/nmeth761
Highly efficient molecular delivery into mammalian cells using carbon nanotube spearing
Dong Cai (2005)
10.1016/j.jconrel.2011.02.015
Tumor targeted quantum dot-mucin 1 aptamer-doxorubicin conjugate for imaging and treatment of cancer.
Ronak Savla (2011)
10.1515/9783111576855-016
K
Martin P. Catherwood (1824)
10.2217/17435889.1.1.5
Welcome to Nanomedicine
C. Martin (2006)
Improved body distribution of 14Clabelled AZT bound to Mataraza nanoparticles in rats determined by radioluminography
R Lobenberg (1998)
10.1002/CHIN.200822272
New Carbon Materials: Biological Applications of Functionalized Nanodiamond Materials
A. Krueger (2008)
10.1002/jps.22200
Development of PLGA nanoparticles simultaneously loaded with vincristine and verapamil for treatment of hepatocellular carcinoma.
X. R. Song (2010)
10.1002/jgm.848
Polyethylenimine‐based antisense oligodeoxynucleotides of IL‐4 suppress the production of IL‐4 in a murine model of airway inflammation
Jihye Seong (2006)
10.1016/J.IJPHARM.2005.10.010
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.
Donald E. Owens (2006)
10.1016/j.jconrel.2008.10.013
Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting.
Y. Ko (2009)
Drug ratiodependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo
P. G. Tardi (2009)
Nanoparticle - mediated delivery of nuclear factor { kappa } B decoy into lungs ameliorates monocrotaline - induced pulmonary arterial
S Azarmi (2009)
Liposomal encapsulation of 3'-azido-3'-deoxythymidine (AZT) results in decreased bone marrow toxicity and enhanced activity against murine AIDS-induced immunosuppression.
N. Phillips (1991)
10.1016/S0378-5173(96)04782-5
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
10.1016/j.ejpb.2010.12.005
Reversible targeting and controlled release delivery of daunorubicin to cancer cells by aptamer-wrapped carbon nanotubes.
S. M. Taghdisi (2011)
10.1016/0168-3659(93)90180-D
Pulmonary delivery of liposomes
H. Schreier (1993)
10.1038/sj.clpt.6100400
Nanoparticles in Medicine: Therapeutic Applications and Developments
L. Zhang (2008)
10.1159/000096391
Dialysis and Nanotechnology: Now, 10 Years, or Never?
W. Fissell (2006)
10.1080/08982100802457377
HER2-specific affibody-conjugated thermosensitive liposomes (Affisomes) for improved delivery of anticancer agents.
A. Puri (2008)
10.1073/pnas.0809154105
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles
Shanta Dhar (2008)
10.1039/C39930001869
Solid-phase synthesis of dendritic sialoside inhibitors of influenza A virus haemagglutinin
R. Roy (1993)
10.1007/s11095-007-9451-9
Paclitaxel Prodrugs with Sustained Release and High Solubility in Poly(ethylene glycol)-b-poly(ε-caprolactone) Micelle Nanocarriers: Pharmacokinetic Disposition, Tolerability, and Cytotoxicity
M. L. Forrest (2007)
10.1016/j.jconrel.2008.08.017
Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes.
E. Afergan (2008)
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
J. Wu (2007)
10.1080/10611860903112842
Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles
K. B. Kurakhmaeva (2009)
10.1208/pt0804111
Formulation and evaluation of ethosomes for transdermal delivery of lamivudine
S. Jain (2008)
10.1161/HYPERTENSIONAHA.108.121418
Nanoparticle-Mediated Delivery of Nuclear Factor &kgr;B Decoy Into Lungs Ameliorates Monocrotaline-Induced Pulmonary Arterial Hypertension
S. Kimura (2009)
10.1016/J.CARBPOL.2009.11.047
Folate conjugated carboxymethyl chitosan–manganese doped zinc sulphide nanoparticles for targeted drug delivery and imaging of cancer cells
M. Mathew (2010)
10.1021/ja107333g
Polymer-caged nanobins for synergistic cisplatin-doxorubicin combination chemotherapy.
S. Lee (2010)
10.1166/JBN.2005.004
Applications of Carbon Nanotubes in Biotechnology and Biomedicine.
E. Bekyarova (2005)
K . M . Hosny , Ciprofloxacin as ocular liposomal hydrogel
MI Afouna (2010)
10.1016/j.jconrel.2008.07.035
Characterization of carbosilane dendrimers as effective carriers of siRNA to HIV-infected lymphocytes.
Nick D Weber (2008)
10.2174/1874104500802010066
Transcorneal Permeation in a Corneal Device of Non-Steroidal Anti-Inflammatory Drugs in Drug Delivery Systems
R. Valls (2008)
10.5040/9781474284028.0024
S
A. Kumar (1824)
10.1163/092050609X12457418779185
Preparation and Therapeutic Efficacy of Polysorbate-80-Coated Amphotericin B/PLA-b-PEG Nanoparticles
Tianbin Ren (2009)
10.1016/j.nano.2010.09.001
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
Krishnan V Chakravarthy (2011)
10.1002/smll.200801572
Antitumor activity and prolonged survival by carbon-nanotube-mediated therapeutic siRNA silencing in a human lung xenograft model.
Jennifer E. Podesta (2009)
10.1158/0008-5472.CAN-08-1468
Drug delivery with carbon nanotubes for in vivo cancer treatment.
Zhuang Liu (2008)
10.1016/J.IJPHARM.2006.12.005
Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
M. M. Elsayed (2007)
10.1200/JCO.2010.30.5961
First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.
E. Feldman (2011)
10.1016/j.ijpharm.2010.07.021
Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis.
Rohit S. Mulik (2010)
10.1016/J.IJPHARM.2004.03.013
In vivo gene transfection via intravitreal injection of cationic liposome/plasmid DNA complexes in rabbits.
S. Kawakami (2004)
10.1016/j.nano.2010.01.002
Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes.
V. Dubey (2010)
10.1158/1535-7163.MCT-09-0243
Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo
P. Tardi (2009)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar